Identifying individuals who are likely to develop Alzheimer disease (AD) will become important with the potential development of therapies that need to
Holiga, StefanAbdulkadir, AhmedKlöppel, StefanDukart, Juergen
Štefan HoligaAhmed AbdulkadirStefan KlöppelJuergen Dukart
Adam FleisherWes S. HoustonLisa T. EylerSusan FryeCecily JenkinsLeon J. ThalMark W. Bondi
Karen T. CuencoRobert C. GreenJ. ZhangKathryn L. LunettaPorat M. ErlichL. Adrienne CupplesLindsay A. FarrerCharles DeCarlifor the MIRAGE Study Group